These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37612754)

  • 1. Women's empowerment and uptake of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy: results from a cross-sectional baseline survey in the Lake endemic region, Kenya.
    Odwe G; Matanda DJ; Zulu T; Kizito S; Okoth O; Kangwana B
    Malar J; 2023 Aug; 22(1):241. PubMed ID: 37612754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya.
    Mutanyi JA; Onguru DO; Ogolla SO; Adipo LB
    Infect Dis Poverty; 2021 Aug; 10(1):106. PubMed ID: 34362443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
    Yaya S; Kota K; Buh A; Bishwajit G
    BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is improvement in indicators of women's empowerment associated with uptake of WHO recommended IPTp-SP levels in sub-Saharan Africa? A multilevel approach.
    Ameyaw EK; Njue C; Amoah RM; Appiah F; Baatiema L; Ahinkorah BO; Seidu AA; Ganle JK; Yaya S
    BMJ Open; 2021 Oct; 11(10):e047606. PubMed ID: 34716158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey.
    Ameyaw EK
    Malar J; 2022 Oct; 21(1):285. PubMed ID: 36207727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania.
    Exavery A; Mbaruku G; Mbuyita S; Makemba A; Kinyonge IP; Kweka H
    Malar J; 2014 Jan; 13():22. PubMed ID: 24423279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of optimal uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine and outcome of pregnancy in selected health facilities: a cross-sectional study in Northern Ghana.
    Agyeman YN; Bassoumah B; Owusu-Marfo J
    Malar J; 2023 Mar; 22(1):80. PubMed ID: 36879278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of four or more doses of sulfadoxine pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Zambia: findings from the 2018 malaria in pregnancy survey.
    Sinyange D; Mukumbuta N; Mutale LS; Mumbole H; Hamainza B; Sialubanje C
    BMJ Open; 2023 May; 13(5):e073287. PubMed ID: 37236665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda.
    Martin MK; Venantius KB; Patricia N; Bernard K; Keith B; Allen K; Godfrey A; Rogers T; Damazo KT; Dathan BM
    Malar J; 2020 Apr; 19(1):153. PubMed ID: 32295601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
    Hill J; Ouma P; Oluoch S; Bruce J; Kariuki S; Desai M; Webster J
    Malar J; 2020 Nov; 19(1):433. PubMed ID: 33238999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of young mothers with the uptake of Sulfadoxine-Pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a cross-sectional study in the Lake endemic region, Kenya.
    Matanda DJ; Zulu T; Odwe G; Okoth O; Nakuya Z
    Front Glob Womens Health; 2024; 5():1294893. PubMed ID: 38596532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
    Olugbade OT; Ilesanmi OS; Gubio AB; Ajayi I; Nguku PM; Ajumobi O
    Pan Afr Med J; 2019; 32(Suppl 1):13. PubMed ID: 30949287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.